UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039152
Receipt number R000044633
Scientific Title Effects and safety of acupuncture treatment with renal jinyuketsu stimulation on blood cytokines in healthy subjects: a randomized control open trial (phase I)
Date of disclosure of the study information 2020/01/15
Last modified on 2021/07/16 09:18:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects and safety of acupuncture treatment with renal jinyuketsu stimulation on blood cytokines in healthy subjects: a randomized control open trial (phase I)

Acronym

Effects and safety of acupuncture treatment on blood cytokines in healthy subjects

Scientific Title

Effects and safety of acupuncture treatment with renal jinyuketsu stimulation on blood cytokines in healthy subjects: a randomized control open trial (phase I)

Scientific Title:Acronym

Effects and safety of acupuncture treatment with renal jinyuketsu stimulation on blood cytokines in healthy subjects: a randomized control open trial (phase I)

Region

Japan


Condition

Condition

healthy subjects

Classification by specialty

Neurology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of acupuncture treatment with jinyuketu stimulation on blood cytokines and safety in healthy subjects

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The changes of serum IL-10 levels after acupuncture treatment

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

acupuncture treatment with jinyuketsu

Interventions/Control_2

acupuncture treatment without jinyuketsu

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Of the subjects who applied for this study voluntarily and obtained consent before the study, they were healthy subjects aged 20 years or older at the time of obtaining consent, and were judged to be appropriate as subjects.

Key exclusion criteria

1) Subjects with a history of immune disease
2) Subjects with immune disease
3) Subjects with skin disease at treatment site
4) Subjects with a history of decreased blood pressure or syncope due to acupuncture treatment
5) Subjects with steroid or immunosuppressants
Others who are considered inappropriate by the investigators

Target sample size

16


Research contact person

Name of lead principal investigator

1st name Akiyuki
Middle name
Last name Uzawa

Organization

Graduate School of Medicine, Chiba University

Division name

Neurology

Zip code

260-8670

Address

1-8-1 Inohana, Chuo-ku, Chiba

TEL

043-226-2129

Email

auzawa@chiba-u.jp


Public contact

Name of contact person

1st name Akiyuki
Middle name
Last name Uzawa

Organization

Graduate School of Medicine, Chiba University

Division name

Neurology

Zip code

260-8670

Address

1-8-1 Inohana, Chuo-ku, Chiba

TEL

043-226-2129

Homepage URL


Email

auzawa@chiba-u.jp


Sponsor or person

Institute

Chiba University

Institute

Department

Personal name



Funding Source

Organization

Chiba University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chiba University

Address

1-8-1 Inohana, Chuo-ku, Chiba

Tel

043-222-7171

Email

prc-jim@chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 01 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 12 Month 03 Day

Date of IRB

2020 Year 02 Month 17 Day

Anticipated trial start date

2020 Year 02 Month 25 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry

2021 Year 07 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 01 Month 14 Day

Last modified on

2021 Year 07 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044633


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name